We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-21.35%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$2.43B
AUM Growth
-$314M
Cap. Flow
-$88.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
48.1%
Holding
447
New
130
Increased
120
Reduced
90
Closed
66

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$38.8M
2
BIIB icon
Biogen
BIIB
+$26M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$23.3M
4
VTRS icon
Viatris
VTRS
+$21M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$16.2M

Top Sells

Rank Stock Value
1
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$28.9M
2
MRK icon
Merck
MRK
+$17.9M
3
XOM icon
ExxonMobil
XOM
+$14.8M
4
ZGNX
Zogenix, Inc.
ZGNX
+$13.4M
5
LPCN icon
Lipocine
LPCN
+$7.13M

Sector Composition

Rank Sector Weight
1 Healthcare 13.39%
2 Energy 1.08%
3 Technology 0.46%
4 Materials 0.45%
5 Consumer Discretionary 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTRS icon
26
Viatris
VTRS
$20.8B
$15.2M 0.63%
+376,827
New +$21M
PXD
27
DELISTED
Pioneer Natural Resource Co.
PXD
$15M 0.62%
123,600
+47,327
+62% +$5.9M
PXD
28
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
$15M 0.62%
1,236
– –
GBT
29
DELISTED
Global Blood Therapeutics, Inc.
GBT
$14.5M 0.6%
+342,857
New +$16.2M
ALNY icon
30
CALL
Alnylam Pharmaceuticals
ALNY
$38.5B
$13.5M 0.55%
1,676
-2,481
-60% -$276K
LUMO
31
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$13.3M 0.55%
411
+64
+18% +$28.1K
ABBV icon
32
PUT
AbbVie
ABBV
$465B
$12.4M 0.51%
2,272
-1,432
-39% -$93.2K
AAPL icon
33
CALL
Apple
AAPL
$4.99T
$12.2M 0.5%
+4,440
New +$130K
UTHR icon
34
CALL
United Therapeutics
UTHR
$26.1B
$12M 0.5%
918
+382
+71% +$61.3K
IOC
35
PUT
DELISTED
Interoil Corporation
IOC
$11.3M 0.47%
3,356
– –
IOC
36
DELISTED
Interoil Corporation
IOC
$11.1M 0.46%
328,705
+175,561
+115% +$7.1M
EW icon
37
Edwards Lifesciences
EW
$48.2B
$11M 0.45%
463,530
+356,640
+334% +$8.61M
THC icon
38
PUT
Tenet Healthcare
THC
$22.6B
$10.7M 0.44%
2,907
-3,241
-53% -$167K
MBLY
39
DELISTED
Mobileye N.V.
MBLY
$10.7M 0.44%
235,819
+161,987
+219% +$8.9M
HRTX icon
40
CALL
Heron Therapeutics
HRTX
$92M
$10.3M 0.42%
4,223
+938
+29% +$31.3K
CEMP
41
CALL
DELISTED
Cempra, Inc.
CEMP
$10.2M 0.42%
3,649
+3,148
+628% +$117K
KITE
42
PUT
DELISTED
Kite Pharma, Inc.
KITE
$10.2M 0.42%
1,823
+1,721
+1,687% +$108K
MNKD icon
43
CALL
MannKind Corp
MNKD
$1.21B
$9.93M 0.41%
6,186
+2,895
+88% +$61.5K
GEVO icon
44
Gevo
GEVO
$363M
$9.82M 0.4%
250
-188
-43% -$175K
THC icon
45
Tenet Healthcare
THC
$22.6B
$9.08M 0.37%
+245,938
New +$12.7M
AGIO icon
46
PUT
Agios Pharmaceuticals
AGIO
$2.14B
$8.28M 0.34%
1,173
+837
+249% +$81.8K
RGLS
47
CALL
DELISTED
Regulus Therapeutics
RGLS
$7.93M 0.33%
101
+3
+3% +$3.08K
TENX icon
48
Tenax Therapeutics
TENX
$419M
$7.89M 0.33%
81
-3
-4% -$343K
AGIO icon
49
Agios Pharmaceuticals
AGIO
$2.14B
$7.73M 0.32%
+109,521
New +$10.7M
ALXN
50
DELISTED
Alexion Pharmaceuticals
ALXN
$7.72M 0.32%
49,397
+33,502
+211% +$6.11M
1
2
3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2015 Portfolio in Review

As of Q3 2015, Sabby Management held 447 positions worth $2.43B, down 11% from $2.74B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sabby Management withdrew a net $88.1M in Q3 2015, closing 66 positions and reducing 90 holdings. Its most notable exit was iShares 20+ Year Treasury Bond ETF, an estimated $28.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 8.3% a quarter earlier, followed by Energy and Technology.

Against the trend, Sabby Management opened a new position in iShares Russell 2000 ETF worth $35.7M.

  • Sabby Management's largest Q3 2015 buy was iShares Russell 2000 ETF: 327,168 shares worth $35.7M.
  • Sabby Management added most to Mobileye N.V. in Q3 2015, an estimated $8.9M increase.
  • Sabby Management's biggest Q3 2015 reduction was Lipocine, cutting an estimated $7.13M.
  • Sabby Management fully exited iShares 20+ Year Treasury Bond ETF in Q3 2015, selling an estimated $28.9M.
  • Sabby Management's ten largest holdings make up 48% of its $2.43B portfolio in Q3 2015.
  • Sabby Management opened 130 new positions and closed 66 in Q3 2015.
  • Sabby Management's portfolio value fell 11% quarter-over-quarter to $2.43B.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.